相似文献
1
In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.
J Clin Microbiol. 2004 Sep;42(9):4319-20. doi: 10.1128/JCM.42.9.4319-4320.2004.
2
[In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole].
Rev Soc Bras Med Trop. 2007 Jan-Feb;40(1):60-2. doi: 10.1590/s0037-86822007000100012.
3
In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms.
Can J Microbiol. 2006 Sep;52(9):843-7. doi: 10.1139/w06-040.
4
In vitro activity of itraconazole in combination with terbinafine against clinical strains of itraconazole-insensitive Sporothrix schenckii.
Eur J Dermatol. 2011 Jul-Aug;21(4):573-6. doi: 10.1684/ejd.2011.1400.
5
Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Braz J Microbiol. 2021 Mar;52(1):135-143. doi: 10.1007/s42770-020-00328-8. Epub 2020 Jul 2.
6
Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
Med Mycol. 2017 Jul 1;55(5):507-517. doi: 10.1093/mmy/myw103.
7
In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.
Med Mycol. 2017 Nov 1;55(8):869-876. doi: 10.1093/mmy/myw143.
8
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
Med Mycol. 2001 Aug;39(4):369-71. doi: 10.1080/mmy.39.4.369.371.
9
Sporothrix schenckii associated with armadillo hunting in Southern Brazil: epidemiological and antifungal susceptibility profiles.
Rev Soc Bras Med Trop. 2010 Sep-Oct;43(5):523-5. doi: 10.1590/s0037-86822010000500010.
10
Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Sporothrix schenckii Complex in Medellin, Colombia.
Mycopathologia. 2019 Feb;184(1):53-63. doi: 10.1007/s11046-018-0310-5. Epub 2018 Dec 15.
引用本文的文献
1
Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Braz J Microbiol. 2021 Mar;52(1):135-143. doi: 10.1007/s42770-020-00328-8. Epub 2020 Jul 2.
2
Synthesis, Stability Studies, and Antifungal Evaluation of Substituted α- and β-2,3-Dihydrofuranaphthoquinones against and .
Molecules. 2019 Mar 7;24(5):930. doi: 10.3390/molecules24050930.
3
Successful Treatment of Canine Sporotrichosis with Terbinafine: Case Reports and Literature Review.
Mycopathologia. 2018 Apr;183(2):471-478. doi: 10.1007/s11046-017-0225-6. Epub 2017 Dec 8.
4
Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01057-17. Print 2017 Oct.
5
Morphological and physiological comparison of taxa comprising the Sporothrix schenckii complex.
J Zhejiang Univ Sci B. 2015 Nov;16(11):940-7. doi: 10.1631/jzus.B1500055.
6
Sporotrichosis: an overview and therapeutic options.
Dermatol Res Pract. 2014;2014:272376. doi: 10.1155/2014/272376. Epub 2014 Dec 29.
7
Influence of different media, incubation times, and temperatures for determining the MICs of seven antifungal agents against Paracoccidioides brasiliensis by microdilution.
J Clin Microbiol. 2013 Feb;51(2):436-43. doi: 10.1128/JCM.02231-12. Epub 2012 Nov 21.
8
Sporothrix schenckii and Sporotrichosis.
Clin Microbiol Rev. 2011 Oct;24(4):633-54. doi: 10.1128/CMR.00007-11.
9
Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil.
J Clin Microbiol. 2011 Aug;49(8):3047-9. doi: 10.1128/JCM.00255-11. Epub 2011 Jun 8.
10
Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis.
Mycopathologia. 2011 May;171(5):349-54. doi: 10.1007/s11046-010-9380-8. Epub 2010 Nov 21.
本文引用的文献
1
Recurrence of sporotrichosis in cats with zoonotic involvement.
Rev Iberoam Micol. 2001 Sep;18(3):137-40.
2
Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis.
Mycoses. 2004 Feb;47(1-2):62-8. doi: 10.1046/j.1439-0507.2003.00953.x.
3
In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis.
J Clin Microbiol. 2002 Aug;40(8):2828-31. doi: 10.1128/JCM.40.8.2828-2831.2002.
4
Sporotrichosis.
Int J Dermatol. 2001 Dec;40(12):737-42. doi: 10.1046/j.1365-4362.2001.01295.x.
5
Case report. Successfully treated subcutaneous infection with Sporothrix schenckii in Turkey.
Mycoses. 2001;44(7-8):330-3.
6
Sporotrichosis: an emergent zoonosis in Rio de Janeiro.
Mem Inst Oswaldo Cruz. 2001 Aug;96(6):777-9. doi: 10.1590/s0074-02762001000600006.
7
Activity of terbinafine against serious fungal pathogens.
Mycoses. 1999;42 Suppl 2:115-9.
8
Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.
Mycoses. 1999;42 Suppl 2:111-4.
9
Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan.
Mycoses. 2000;43(1-2):79-83. doi: 10.1046/j.1439-0507.2000.00548.x.
10
An evaluation of the in vitro activity of terbinafine.
Med Mycol. 2000 Apr;38(2):155-9. doi: 10.1080/mmy.38.2.155.159.
Zotero 插件